메뉴 건너뛰기
Annals of Oncology
Volumn 18, Issue 3, 2007, Pages 609-610
Does low-molecular-weight heparin influence cancer-related mortality? [8]
Author keywords

[No Author keywords available]
Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;
EID: 33847628465     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl487     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 33749628120 scopus 로고    scopus 로고
    • Does low-molecular-weight heparin influence cancer-related mortality?
    • Ferretti G, Bria E, Giannarelli D et al. Does low-molecular-weight heparin influence cancer-related mortality? Ann Oncol 2006; 17: 1604-1606.
    • (2006) Ann Oncol , vol.17 , pp. 1604-1606
    • Ferretti, G.1    Bria, E.2    Giannarelli, D.3
  • 2
    • 0037775584 scopus 로고    scopus 로고
    • Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
    • Lee AY, Levine MN, Baker RI et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349 (2): 146-153.
    • (2003) N Engl J Med , vol.349 , Issue.2 , pp. 146-153
    • Lee, A.Y.1    Levine, M.N.2    Baker, R.I.3
  • 3
    • 0037067889 scopus 로고    scopus 로고
    • Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study
    • Meyer G, Marjanovic Z, Valke J et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: A randomized controlled study. Arch Intern Med 2002; 162 (15): 1729-1735.
    • (2002) Arch Intern Med , vol.162 , Issue.15 , pp. 1729-1735
    • Meyer, G.1    Marjanovic, Z.2    Valke, J.3
  • 4
    • 17144385138 scopus 로고    scopus 로고
    • Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous-thromboembolism
    • Lee AY, Rickles FR, Julian JA et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous-thromboembolism. J Clin Oncol 2005; 23 (10): 2123-2129.
    • (2005) J Clin Oncol , vol.23 , Issue.10 , pp. 2123-2129
    • Lee, A.Y.1    Rickles, F.R.2    Julian, J.A.3
  • 5
    • 20244376337 scopus 로고    scopus 로고
    • The effect of low molecular weight heparin on survival patients with advanced malignancy
    • Klerk CP, Smorenburg SM, Otten HM et al. The effect of low molecular weight heparin on survival patients with advanced malignancy. J Clin Oncol 2005; 23 (10): 2119-2120.
    • (2005) J Clin Oncol , vol.23 , Issue.10 , pp. 2119-2120
    • Klerk, C.P.1    Smorenburg, S.M.2    Otten, H.M.3
  • 6
    • 3042704507 scopus 로고    scopus 로고
    • Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)
    • Kakkar AK, Levine MN, Kadziola Z et al. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 2004; 22 (10): 1944-1948.
    • (2004) J Clin Oncol , vol.22 , Issue.10 , pp. 1944-1948
    • Kakkar, A.K.1    Levine, M.N.2    Kadziola, Z.3
  • 7
    • 12844289104 scopus 로고    scopus 로고
    • A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer
    • Altinbas M, Coskun HS, Er O et al. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J Thromb Haemost 2004; 2 (8): 1266-1271.
    • (2004) J Thromb Haemost , vol.2 , Issue.8 , pp. 1266-1271
    • Altinbas, M.1    Coskun, H.S.2    Er, O.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.